DISCO应用:减少癌症经济负担的患者干预随机对照试验研究方案
本研究为纵向随机对照试验,在底特律NCI指定综合癌症中心招募乳腺癌、肺癌、结直肠癌或前列腺癌患者,随机分为常规护理组和两个干预组。干预组在第二次肿瘤科互动前使用iPad上的DISCO应用,提供治疗费用教育视频和个体化问题列表,第三组额外接受强化干预。主要评估费用讨论、沟通质量、费用知识、自我效能、经济毒性及治疗依从性等结局。
要点
- 经济毒性影响30-50%癌症患者,少数族裔、低收入和<65岁人群负担更重。
- DISCO应用提供费用教育视频和个体化问题列表,促进患者与肿瘤医生费用讨论。
- 试验评估费用讨论、沟通质量、经济毒性及治疗依从性等结局。
核心结论
- 若有效,DISCO应用将提高治疗费用意识和讨论,减轻经济毒性负担,促进健康公平。
研究设计与样本
- 纵向随机对照试验,在底特律NCI指定综合癌症中心招募乳腺癌、肺癌、结直肠癌或前列腺癌患者。
- 患者随机分为三组:常规护理组(arm 1)和两个干预组(arm 2和arm 3)。
- 所有干预组患者在第二次与肿瘤科医生互动前接受DISCO应用,arm 3患者额外接受干预强化。
- 所有患者最多两次与肿瘤科医生互动被录像,并在基线、录像互动后及第二次互动后1、3、6、12个月完成测量。
关键数值与推荐
- 经济毒性影响30-50%癌症患者,即使有医疗保险者也受影响。
- 经济毒性不成比例地影响种族/族裔少数、低收入和<65岁患者。
- 患者费用教育和患者-肿瘤科医生费用讨论被推荐用于解决经济毒性,但费用讨论不频繁。
临床怎么用
- DISCO应用可在肿瘤科就诊前提供费用教育视频和个体化问题列表,促进患者与医生费用讨论。
- 干预可能特别有助于受经济毒性影响不成比例的群体,促进健康公平。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Financial toxicity, the material and psychological burden of the cost of treatment, affects 30-50% of people with cancer, even those with health insurance. The burden of treatment cost can affect treatment adherence and, ultimately, mortality. Financial toxicity is a health equity issue, disproportionately affecting patients who are racial/ethnic minorities, have lower incomes, and are < 65 years old. Patient education about treatment cost and patient-oncologist cost discussions are recommended as ways to address financial toxicity; however, research shows cost discussions occur infrequently (Altice et al. J Natl Cancer Inst 109:djw205, 2017; Schnipper et al. J Clin Oncol 34:2925-34, 2016; Zafar et al. Oncologist 18:381-90, 2013; American Cancer Society Cancer Action Network 2010). Our overall goal is to address the burden of financial toxicity and work toward health equity through a tailorable education and communication intervention, the DISCO App. The aim of this longitudinal randomized controlled trial is to test the effectiveness of the DISCO App on the outcomes in a population of economically and racially/ethnically diverse cancer patients from all age groups. METHODS: Patients diagnosed with breast, lung, colorectal, or prostate cancer at a NCI-designated comprehensive cancer center in Detroit, MI, will be randomized to one of three study arms: one usual care arm (arm 1) and two intervention arms (arms 2 and 3). All intervention patients (arms 2 and 3) will receive the DISCO App before the second interaction with their oncologist, and patients in arm 3 will receive an intervention booster. The DISCO App, presented on an iPad, includes an educational video about treatment costs, ways to manage them, and the importance of discussing them with oncologists. Patients enter socio-demographic information (e.g., employment, insurance status) and indicate their financial concerns. They then receive a tailored list of questions to consider asking their oncologist. All patients will have up to two interactions with their oncologist video recorded and complete measures at baseline, after the recorded interactions and at 1, 3, 6, and 12 months after the second interaction. Outcome measures will assess discussions of cost, communication quality, knowledge of treatment costs, self-efficacy for treatment cost management, referrals for support, short- and longer-term financial toxicity, and treatment adherence. DISCUSSION: If effective, this intervention will improve awareness of and discussions of treatment cost and alleviate the burden of financial toxicity. It may be especially helpful to groups disproportionately affected by financial toxicity, helping to achieve health equity. TRIAL REGISTRATION: ClinicalTrials.gov NCT04766190. Registered on February 23, 2021.
引用
- Hamel LM, Dougherty DW, Kim S, et al. DISCO App: study protocol for a randomized controlled trial to test the effectiveness of a patient intervention to reduce the financial burden of cancer in a diverse patient population. Trials. 2021. PMID: 34535162. doi:10.1186/s13063-021-05593-y
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。